National Vision price target lowered to $19 from $23 at Barclays

Barclays lowered the firm’s price target on National Vision to $19 from $23 and keeps an Equal Weight rating on the shares. The company reported Q3 results that exceeded expectations and the remote exam roll out continues to improve doctor capacity utilization, the analyst tells investors in a research note.